Literature DB >> 23047870

Melanoma cells inhibit NK cell functions.

Giuseppe Sconocchia, Roberto Arriga, Luigi Tornillo, Luigi Terracciano, Soldano Ferrone, Giulio C Spagnoli.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23047870     DOI： 10.1158/0008-5472.CAN-12-1181

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  33 in total

1.  IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.

Authors:  Joe-Marc Chauvin; Mignane Ka; Ornella Pagliano; Carmine Menna; Quanquan Ding; Richelle DeBlasio; Cindy Sanders; Jiajie Hou; Xian-Yang Li; Soldano Ferrone; Diwakar Davar; John M Kirkwood; Robert J Johnston; Alan J Korman; Mark J Smyth; Hassane M Zarour
Journal:  Clin Cancer Res       Date:  2020-06-26       Impact factor: 12.531

2.  HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger-Castori; Inti Zlobec; Eva Karamitopoulou; Roberto Arriga; Andrea Coppola; Sara Caratelli; Giulio Cesare Spagnoli; Davide Lauro; Alessandro Lugli; Junyi Han; Giandomenica Iezzi; Cristina Ferrone; Amedeo Ferlosio; Luigi Tornillo; Raoul Droeser; Piero Rossi; Antonio Attanasio; Soldano Ferrone; Luigi Terracciano
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

3.  NK cells and T cells cooperate during the clinical course of colorectal cancer.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger; Giulio C Spagnoli; Luigi Tornillo; Raoul Droeser; Sara Caratelli; Francesca Ferrelli; Andrea Coppola; Roberto Arriga; Davide Lauro; Giandomenica Iezzi; Luigi Terracciano; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2014-08-03       Impact factor: 8.110

Review 4.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

5.  Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.

Authors:  Timothy J Zumwalt; Ajay Goel
Journal:  Curr Colorectal Cancer Rep       Date:  2015-06-29

6.  The clinical and biological significance of MICA in clear cell renal cell carcinoma patients.

Authors:  Xiang Zhang; Lei Yan; Wei Jiao; Juchao Ren; Naidong Xing; Yongzhen Zhang; Yuanwei Zang; Jue Wang; Zhonghua Xu
Journal:  Tumour Biol       Date:  2015-09-09

7.  Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.

Authors:  Silvio Däster; Serenella Eppenberger-Castori; Christian Hirt; Savas D Soysal; Tarik Delko; Christian A Nebiker; Benjamin Weixler; Francesca Amicarella; Giandomenica Iezzi; Valeria Governa; Elisabetta Padovan; Valentina Mele; Giuseppe Sconocchia; Michael Heberer; Luigi Terracciano; Christoph Kettelhack; Daniel Oertli; Giulio C Spagnoli; Urs von Holzen; Luigi Tornillo; Raoul A Droeser
Journal:  Oncoimmunology       Date:  2015-05-29       Impact factor: 8.110

8.  CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.

Authors:  Roberto Arriga; Sara Caratelli; Giulia Lanzilli; Alessio Ottaviani; Carlo Cenciarelli; Tommaso Sconocchia; Giulio C Spagnoli; Giandomenica Iezzi; Mario Roselli; Davide Lauro; Andrea Coppola; Gianpietro Dotti; Soldano Ferrone; Giuseppe Sconocchia
Journal:  Int J Cancer       Date:  2019-08-30       Impact factor: 7.396

Review 9.  Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Cell Oncol (Dordr)       Date:  2018-02-22       Impact factor: 6.730

10.  Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity.

Authors:  Siyu Tan; Xiaowei Guo; Mengzhen Li; Tixiao Wang; Zehua Wang; Chunyang Li; Zhuanchang Wu; Nailin Li; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  J Exp Med       Date:  2021-07-19       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.